Therapy News and Research

RSS

Researchers discover how ovarian cancer hides from the body's immune system

Researchers at the University of Helsinki discovered how ovarian cancer hides from the body's immune system. The findings will help develop novel precision therapies for ovarian cancer, a common and aggressive cancer type.

12 Feb 2022

Stroke rehabilitation experts propose a new paradigm for improving treatment of spatial neglect

Kessler Foundation experts in stroke rehabilitation proposed a new paradigm for improving treatment of spatial neglect, a disabling condition that hinders recovery for at least 30 percent of stroke survivors.

11 Feb 2022

Mechanical blood clot removal helps nearly half of stroke survivors to achieve good outcomes

Mechanical removal of blood clots reduced post-stroke disability in nearly half of "all-comer" real-world stroke patients in an international study, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2022.

11 Feb 2022

Lung cancer patients with coronary artery calcium burden have greater risk of cardiovascular events

Lung cancer patients with higher amounts of coronary artery calcium have an increased risk of an adverse cardiovascular event as a result of thoracic radiation therapy compared to patients with no coronary artery calcium.

11 Feb 2022

First unbiased proteome scale study expands the number of known transcriptional activators

Also known as transcriptional activators for their ability to induce transcription of genes into RNA messages, these proteins are essential for the cells to function properly. Yet little is known about these proteins, and it wasn't clear how many activators there might be in human cells – until now.

11 Feb 2022

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

A survey demonstrated that patients with systemic autoimmune rheumatic diseases commonly experience augmented disease severity and disrupted treatment regimens of disease-modifying antirheumatic drugs after acute COVID-19 course.

11 Feb 2022

Scientists decipher molecular cause of cerebral venous thrombosis

Cerebral venous thrombosis is a rare, often severe disease that has been brought to public attention by the Covid 19 pandemic. A research group from Würzburg has now succeeded for the first time in deciphering a molecular cause of this disease.

11 Feb 2022

Model shows booster doses and antiviral pills may enable relaxation of SARS-CoV-2 social distancing

Researchers suggest that social distancing could be relaxed in order to reduce the number of severe cases of COVID-19, rather than stop the transmission of the SARS-CoV-2.

11 Feb 2022

Challenges in safely deprescribing common anticholinergic drugs

Medications with anticholinergic properties have been consistently associated with a wide range of adverse outcomes for older adults including cognitive impairment, yet these drugs continue to be commonly prescribed for depression, urinary incontinence, irritable bowel syndrome and Parkinson's disease.

11 Feb 2022

Showcasing STEM Women in Medical Science

Every year, the UN celebrates the International Day of Women and Girls in Science. For 2022, the focus is placed on recognizing the role women and girls play in STEM as beneficiaries and as agents of change.

11 Feb 2022

Newer clot-busting drug may lengthen the window for additional stroke treatment to 24 hours

If patients with clot-caused strokes obtain medical care more than 4½ hours after their symptoms are noticed, it is too late to receive the standard clot-busting medication alteplase.

11 Feb 2022

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Alkem Laboratories Limited, an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University's Office of Technology Development enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.

11 Feb 2022

Molecular treatment works against metastatic cancer that spread to the brain

Mount Sinai researchers conducting clinical trials of a drug targeting a cancer gene found that it increased metastatic cancer patients' survival and was able to work within the brain, according to a study published in Clinical Cancer Research in February.

10 Feb 2022

Artificial intelligence uses facial features to better diagnose rare genetic diseases

Rare genetic diseases can sometimes be recognized through facial features, such as characteristically shaped brows, nose or cheeks.

10 Feb 2022

New protocol for transplanting 3D cellular structures to regenerate damaged intestinal tissue

Ulcerative colitis is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the digestive tract. Ulcerative colitis affects the innermost lining of the colon and rectum.

10 Feb 2022

Gene variants associated with acute kidney injury in Black veterans hospitalized with COVID-19

Gene variants increased the risk of acute kidney injury and death in veterans of African ancestry who were hospitalized with COVID-19, according to a new study published in JAMA Internal Medicine.

10 Feb 2022

New analysis highlights growing trends in combination cancer therapy clinical trials

The Cancer Research Institute, a nonprofit organization dedicated to the discovery and development of powerful immunotherapies for all types of cancer, announced today the publication of its newest analysis of the global landscape of clinical development of drugs that target the PD1/PDL1 immune checkpoint pathway.

10 Feb 2022

Therapy News and Research

Researchers discover how ovarian cancer hides from the body's immune system

Stroke rehabilitation experts propose a new paradigm for improving treatment of spatial neglect

Mechanical blood clot removal helps nearly half of stroke survivors to achieve good outcomes

Lung cancer patients with coronary artery calcium burden have greater risk of cardiovascular events

First unbiased proteome scale study expands the number of known transcriptional activators

The impact of COVID-19 on people with systemic autoimmune rheumatic diseases

Scientists decipher molecular cause of cerebral venous thrombosis

Model shows booster doses and antiviral pills may enable relaxation of SARS-CoV-2 social distancing

Challenges in safely deprescribing common anticholinergic drugs

Showcasing STEM Women in Medical Science

Newer clot-busting drug may lengthen the window for additional stroke treatment to 24 hours

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Molecular treatment works against metastatic cancer that spread to the brain

Artificial intelligence uses facial features to better diagnose rare genetic diseases

New protocol for transplanting 3D cellular structures to regenerate damaged intestinal tissue

Gene variants associated with acute kidney injury in Black veterans hospitalized with COVID-19

New analysis highlights growing trends in combination cancer therapy clinical trials

New rapid, cheaper test could help advance personalized cancer treatment

New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

Neutralizing antibody ABP-310 found to be highly potent against SARS-CoV-2 variants including Omicron

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News